Year archive

Opthea Ltd — 2024 filings

All 150 regulatory filings released by Opthea Ltd (OPT) in 2024, sourced directly from the official regulator.

150 Filings

2024 Period

2024 filings (150)

Filing	Released	Lang
Notification regarding unquoted securities - OPT 6 pages 18.5KB Share Issue/Capital Change	2024-12-23	English
Notification of cessation of securities - OPT 4 pages 14.8KB Regulatory Filings	2024-12-23	English
Notification regarding unquoted securities - OPT 6 pages 18.5KB Share Issue/Capital Change	2024-12-23	English
Application for quotation of securities - OPT 6 pages 18.8KB Share Issue/Capital Change	2024-12-23	English
6-K Regulatory Filings	2024-12-19	English
Opthea to Present at 43rd J.P. Morgan Healthcare Conference 1 Investor Presentation	2024-12-18	English
Change of Director's Interest Notice - JL 3 pages 1.0MB Director's Dealing	2024-12-16	English
Change of Director's Interest Notice -AT 3 pages 1.0MB Director's Dealing	2024-12-16	English
Change of Director's Interest Notice - JH 3 pages 1.0MB Director's Dealing	2024-12-16	English
Change of Director's Interest Notice - LG 4 pages 861.2KB Director's Dealing	2024-12-16	English
Change of Director's Interest Notice - QO 3 pages 1.0MB Director's Dealing	2024-12-16	English
Change of Director's Interest Notice - SO 3 pages 1.0MB Director's Dealing	2024-12-16	English
Change of Director's Interest Notice - SS 3 pages 1.0MB Director's Dealing	2024-12-16	English
Notification regarding unquoted securities - OPT 7 pages 20.8KB Share Issue/Capital Change	2024-12-15	English
Notification regarding unquoted securities - OPT 6 pages 19.3KB Share Issue/Capital Change	2024-12-15	English
Notification regarding unquoted securities - OPT 6 pages 18.9KB Share Issue/Capital Change	2024-12-15	English
Notification regarding unquoted securities - OPT 6 pages 18.8KB Share Issue/Capital Change	2024-12-15	English
6-K Regulatory Filings	2024-11-26	English
Opthea's Wet AMD Program to be Featured at FLORetina 2024 2 pages 388.4KB Regulatory Filings	2024-11-25	English
6-K Regulatory Filings	2024-11-25	English
Opthea Participate in Citi 2024 Global Healthcare Conference 1 Investor Presentation	2024-11-24	English
6-K Regulatory Filings	2024-11-19	English
6-K Regulatory Filings	2024-11-15	English
Chair's Address to Shareholders 4 pages 241.8KB AGM Information	2024-11-14	English
Director Appointment/Resignation 3 pages 475.4KB Board/Management Information	2024-11-14	English
Results of Meeting 2 pages 354.4KB Declaration of Voting Results & Voting Rights Announcements	2024-11-14	English
Opthea Received A$15.9 Million R&D Tax Incentive 2 pages 223.2KB Capital/Financing Update	2024-11-14	English
Initial Director's Interest Notice 2 pages 806.3KB Director's Dealing	2024-11-14	English
AMENDMENT NO.5 Major Shareholding Notification	2024-11-14	English
6-K Regulatory Filings	2024-11-12	English
Opthea's Wet AMD Program Featured at Ophthalmology Events 2 pages 468.8KB Regulatory Filings	2024-11-11	English
6-K Regulatory Filings	2024-11-04	English
Opthea to Participate in November Investor Conferences 2 pages 457.0KB Investor Presentation	2024-11-03	English
Update Opthea Participates in November Investor Conferences 2 pages 457.5KB Investor Presentation	2024-11-03	English
6-K Regulatory Filings	2024-11-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 1.5MB Interim / Quarterly Report Q1 2025	2024-10-30	English
6-K Regulatory Filings	2024-10-28	English
Opthea Corporate Presentation - Oct 2024 34 pages 1.6MB Investor Presentation	2024-10-27	English
6-K Regulatory Filings	2024-10-16	English
6-K Regulatory Filings	2024-10-16	English
Opthea Files Notice of Annual General Meeting 3 pages 470.0KB AGM Information	2024-10-15	English
Notice of Annual General Meeting/Proxy Form 104 pages 1.3MB AGM Information	2024-10-15	English
6-K Regulatory Filings	2024-10-10	English
Opthea Wet AMD Program to be Presented at Innovate Retina 2 pages 388.8KB Regulatory Filings	2024-10-09	English
6-K Regulatory Filings	2024-10-08	English
Opthea Appoints Chief Medical and Chief Financial Officer 3 pages 480.2KB Board/Management Information	2024-10-07	English
Becoming a substantial holder 5 pages 388.2KB Major Shareholding Notification	2024-10-03	English
Opthea to participate in UBS Virtual Ophthalmology Day 2024 1 Investor Presentation	2024-09-30	English
6-K Regulatory Filings	2024-09-30	English
6-K Regulatory Filings	2024-09-26	English
Opthea EURetina Symposium 2024 67 pages 2.0MB Investor Presentation	2024-09-25	English
6-K Regulatory Filings	2024-09-23	English
Opthea Joins the S&P/ASX 300 Index 3 pages 276.9KB Capital/Financing Update	2024-09-22	English
20-F/A Annual Report FY 2024	2024-09-20	English
Opthea Announces Completion of Drug Substance Campaign 2 pages 472.6KB Capital/Financing Update	2024-09-18	English
6-K Regulatory Filings	2024-09-18	English
Opthea Presents at the 24th EURETINA Congress 3 pages 666.8KB Investor Presentation	2024-09-10	English
6-K Regulatory Filings	2024-09-10	English
6-K Regulatory Filings	2024-09-09	English
Opthea Corporate Presentation - September 2024 34 pages 1.7MB Investor Presentation	2024-09-08	English
6-K Regulatory Filings	2024-09-05	English
Opthea Announces Executive Leadership Changes & Senior Hires 4 pages 550.6KB Board/Management Information	2024-09-04	English
Opthea presents at H.C.Wainwright 26th Investment Conference 2 pages 127.4KB Investor Presentation	2024-09-03	English
6-K Regulatory Filings	2024-09-03	English
20-F Annual Report FY 2024	2024-08-30	English
6-K Regulatory Filings	2024-08-30	English
Opthea Preliminary Final and Annual Report 115 pages 5.1MB Annual Report FY 2024	2024-08-29	English
Opthea Reports Full-Year Results 9 pages 927.4KB Annual Report FY 2024	2024-08-29	English
Opthea 2024 Corporate Governance Statement 28 pages 1.2MB Governance Information	2024-08-29	English
Opthea to Participate in H.C Wainwright Virtual Conference 1 Investor Presentation	2024-08-08	English
6-K Regulatory Filings	2024-08-08	English
Updated Quarterly Report and Cashflow 13 pages 2.3MB Interim / Quarterly Report Q4 2024	2024-07-31	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 550.9KB Interim / Quarterly Report Q4 2024	2024-07-30	English
Change in substantial holding 5 pages 468.0KB Major Shareholding Notification	2024-07-18	English
Change in substantial holding 3 pages 95.3KB Major Shareholding Notification	2024-07-18	English
Opthea Welcomes Retina Leaders to its Medical Advisory Board 4 pages 503.8KB Regulatory Filings	2024-07-17	English
6-K Regulatory Filings	2024-07-17	English
Application for quotation of securities - OPT 6 pages 19.7KB Share Issue/Capital Change	2024-07-16	English
OPTOB - Range of Units 1 page 26.0KB Fund Information / Factsheet	2024-07-16	English
OPTOB Top Holders 2 pages 28.5KB Major Shareholding Notification	2024-07-16	English
Security Class Reinstatement to Quotation- OPTOB 1 Regulatory Filings	2024-07-16	English
6-K Regulatory Filings	2024-07-15	English
Opthea Announces Results of Retail Entitlement of A$55.9m 4 pages 311.9KB Capital/Financing Update	2024-07-14	English
Security Class Suspension from Quotation OPTOB 1 pa Regulatory Filings	2024-07-10	English
Opthea Announces Publication on VEGF- C and D 4 pages 608.6KB Regulatory Filings	2024-07-09	English
6-K Regulatory Filings	2024-07-09	English
AMENDMENT NO. 4 Major Shareholding Notification	2024-07-04	English
Change in substantial holding 5 pages 470.2KB Major Shareholding Notification	2024-06-24	English
Change in substantial holding 5 pages 651.6KB Major Shareholding Notification	2024-06-24	English
Opthea Cleansing Statement 1 page 229.9KB Capital/Financing Update	2024-06-20	English
6-K Regulatory Filings	2024-06-20	English
Application for quotation of securities - OPT 6 pages 18.7KB Share Issue/Capital Change	2024-06-19	English
Opthea A$55.0m (US$36.9m) Retail Entitlement Offer Opens 14 pages 434.2KB Capital/Financing Update	2024-06-18	English
6-K Regulatory Filings	2024-06-14	English
Opthea Completes Placement & Institutional Entitlement Offer 6 pages 622.1KB Capital/Financing Update	2024-06-13	English
6-K Regulatory Filings	2024-06-12	English
6-K Regulatory Filings	2024-06-12	English
6-K Regulatory Filings	2024-06-12	English
Trading Halt - Accelerated Offer 2 pages 330.2KB Capital/Financing Update	2024-06-11	English
Opthea Annouces Equity Raise 8 pages 591.8KB Capital/Financing Update	2024-06-11	English
Opthea Equity Raise Investor Presentation 60 pages 2.4MB Capital/Financing Update	2024-06-11	English
Opthea - Prospectus 2024 78 pages 1.5MB Capital/Financing Update	2024-06-11	English
Proposed issue of securities - OPT 13 pages 42.6KB Capital/Financing Update	2024-06-11	English
Update - Proposed issue of securities - OPT 13 pages 41.9KB Share Issue/Capital Change	2024-06-11	English
Trading Halt 2 pages 611.7KB Capital/Financing Update	2024-06-06	English
6-K Regulatory Filings	2024-06-03	English
Opthea to Present at Clinical Trials at the Summit Meeting 3 pages 395.0KB Investor Presentation	2024-06-02	English
6-K Regulatory Filings	2024-05-28	English
Opthea Completes Enrollment in Phase 3 Clinical Program 4 pages 302.1KB Capital/Financing Update	2024-05-27	English
6-K Regulatory Filings	2024-05-01	English
Opthea Announces Presentations at Retina World Congress 2 pages 397.8KB Investor Presentation	2024-04-30	English
6-K Regulatory Filings	2024-04-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 1.7MB Interim / Quarterly Report Q3 2024	2024-04-29	English
Opthea Presents at the OIS Retina Innovation Summit at ARVO 1 Investor Presentation	2024-04-25	English
6-K Regulatory Filings	2024-04-25	English
Notification regarding unquoted securities - OPT 7 pages 21.1KB Share Issue/Capital Change	2024-04-14	English
Notification regarding unquoted securities - OPT 6 pages 18.3KB Share Issue/Capital Change	2024-04-14	English
6-K Regulatory Filings	2024-04-09	English
Opthea Appoints John Han, PharmD, as VP Medical Affairs 4 pages 633.3KB Board/Management Information	2024-04-08	English
6-K Regulatory Filings	2024-04-05	English
6-K Regulatory Filings	2024-04-05	English
Opteha to Participate in the 23rd Needham Virtual Conference 2 pages 213.0KB Regulatory Filings	2024-04-04	English
Opthea Corporate Presentation - April 2024 31 pages 2.1MB Investor Presentation	2024-04-04	English
6-K Regulatory Filings	2024-04-03	English
Opthea Key Opinion Leader Even on Sozinibercept 46 pages 2.3MB Investor Presentation	2024-04-03	English
Opthea Appoints Sujal Shah to the Board of Directors 4 pages 210.5KB Board/Management Information	2024-04-03	English
Initial Director's Interest Notice Sujal Shah 2 pages 212.8KB Director's Dealing	2024-04-03	English
Final Director's Interest Notice DS 2 pages 235.7KB Director's Dealing	2024-04-03	English
6-K Regulatory Filings	2024-04-03	English
Notification regarding unquoted securities - OPT 7 pages 21.1KB Share Issue/Capital Change	2024-04-01	English
6-K Regulatory Filings	2024-03-19	English
Opthea to Host Key Opinion Leader Event on April 3, 2024 4 pages 223.0KB Investor Presentation	2024-03-18	English
6-K Regulatory Filings	2024-03-06	English
Opthea to Participate in Leerink Global Biopharma Conference 1 Regulatory Filings	2024-03-05	English
6-K Regulatory Filings	2024-03-04	English
Opthea Corporate Presentation - March 2024 30 pages 2.7MB Investor Presentation	2024-03-03	English
Change of Director's Interest Notice 4 pages 321.2KB Director's Dealing	2024-02-29	English
Change of Director's Interest Notice Update 4 pages 322.5KB Director's Dealing	2024-02-29	English
6-K Regulatory Filings	2024-02-28	English
Half Yearly Report and Accounts 38 pages 2.0MB Interim / Quarterly Report H1 2024	2024-02-28	English
Opthea Reports Half-Year Results and Business Update 5 pages 176.5KB Interim / Quarterly Report H1 2024	2024-02-28	English
6-K Regulatory Filings	2024-02-20	English
Opthea Appoints Arshard M Khanani as Chief Medical Advisor 3 pages 478.6KB Board/Management Information	2024-02-19	English
SC 13G/A Major Shareholding Notification	2024-02-14	English
AMENDMENT NO. 3 Major Shareholding Notification	2024-02-14	English
Opthea Completes Enrollment in First Trial of Sozinibercept 4 pages 163.0KB Capital/Financing Update	2024-02-14	English
6-K Regulatory Filings	2024-02-14	English
Opthea Strengthens Team with Key Clinical & Regulatory Hires 3 pages 140.4KB Board/Management Information	2024-02-01	English
6-K Regulatory Filings	2024-02-01	English
6-K Regulatory Filings	2024-01-11	English

Filings by year

2026 5 filings
2025 97 filings
2024 150 filings
2023 108 filings
2022 143 filings
2021 117 filings
2020 100 filings
2019 59 filings
2018 52 filings
2017 49 filings
2016 27 filings
2015 1 filing
2014 46 filings
2013 38 filings
2012 43 filings
2011 47 filings
2010 42 filings
2009 38 filings
2008 56 filings
2007 34 filings
2006 29 filings
2005 20 filings
2004 27 filings
2003 57 filings
2002 5 filings